Clinical Trial Update: A Prospective, Multicenter, Phase II Clinical Study on the Treatment of Unresectable Advanced HCC with DEB-TACE Combined with SALOX-HAIC

View source ↗

Summary

This entry reports a prospective multicenter Phase II clinical study evaluating DEB-TACE combined with SALOX-HAIC for unresectable advanced hepatocellular carci…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• DEB-TACE
• SALOX-HAIC

Snippet

Sponsor: Xuhua Duan | Conditions: Hepatocellular Carcinoma | Status: NOT_YET_RECRUITING